We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.65B
1-Year Est. Return
203.21%
This Fund
S&P 500
This Quarter
Est. Return
+12.45%
1 Year Est. Return
+203.21%
3 Year Est. Return
+364.25%
5 Year Est. Return
+595.91%
10 Year Est. Return
+10,683%
AUM
$620M
AUM Growth
-$22.5M
(-3.5%)
Cap. Flow
-$102M
Cap. Flow
% of AUM
-16.42%
Top 10 Holdings %
Top 10 Hldgs %
56.57%
Holding
63
New
7
Increased
6
Reduced
34
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XENT
Intersect ENT, Inc
XENT
|
+$8.69M |
| 2 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
+$5.06M |
| 3 |
Veracyte
VCYT
|
+$3.37M |
| 4 |
Invesco S&P SmallCap Health Care ETF
PSCH
|
+$2.38M |
| 5 |
CLLS
Cellectis
CLLS
|
+$2.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tandem Diabetes Care
TNDM
|
+$57.3M |
| 2 |
NeoGenomics
NEO
|
+$20.2M |
| 3 |
AtriCure
ATRC
|
+$13M |
| 4 |
Ligand Pharmaceuticals
LGND
|
+$11.9M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
+$9.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 94.32% |
| 2 | Communication Services | 3.41% |
| 3 | Miscellaneous | 1.37% |
| 4 | Energy | 0.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Johnson & Johnson
JNJ
$644B
| $302K | 0.05% |
2,183
| – | – |
|
52
Sanofi
SNY
$102B
| $300K | 0.05% |
6,720
| – | – |
|
53
Amgen
AMGN
$203B
| $229K | 0.04% |
1,105
| – | – |
|
54
Revvity
RVTY
$15.6B
| $221K | 0.04% |
+2,270
| New | +$195K |
|
55
Elevance Health
ELV
$90.6B
| $220K | 0.04% |
+803
| New | +$208K |
|
56
HCA Healthcare
HCA
$91.8B
| $210K | 0.03% |
+1,513
| New | +$188K |
|
57
Teleflex
TFX
$5.47B
| $208K | 0.03% |
783
| – | – |
|
|
HRC
58
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $202K | 0.03% |
+2,144
| New | +$201K |
|
|
STRM
59
DELISTED
Streamline Health Solutions
STRM
| $47K | 0.01% |
2,647
-112,297
| -98% | -$2.15M |
|
60
IRIDEX
IRIX
$11.1M
| – | – |
-198,581
| Closed | -$1.38M |
|
|
NVRO
61
DELISTED
NEVRO CORP.
NVRO
| – | – |
-116,224
| Closed | -$9.28M |
|
|
CELG
62
DELISTED
Celgene Corp
CELG
| – | – |
-14,742
| Closed | -$1.17M |
|
|
XLVS
63
DELISTED
POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS
| – | – |
-17,285
| Closed | -$2.22M |
|
Similar funds
AAM
NPA
SOS
BCM
BFO
AAG
MCIL
TIM
First Light Asset Management's Q3 2018 Portfolio in Review
As of Q3 2018, First Light Asset Management held 63 positions worth $620M, down 3.5% from $642M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
First Light Asset Management withdrew a net $102M in Q3 2018, closing 4 positions and reducing 34 holdings. Its most notable exit was NEVRO CORP., an estimated $9.28M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 94% a quarter earlier, followed by Communication Services and Miscellaneous.
Against the trend, First Light Asset Management opened a new position in Invesco S&P SmallCap Health Care ETF worth $2.43M.
- First Light Asset Management's largest Q3 2018 buy was Invesco S&P SmallCap Health Care ETF: 51,855 shares worth $2.43M.
- First Light Asset Management added most to Intersect ENT, Inc in Q3 2018, an estimated $8.69M increase.
- First Light Asset Management's biggest Q3 2018 reduction was Tandem Diabetes Care, cutting an estimated $57.3M.
- First Light Asset Management fully exited NEVRO CORP. in Q3 2018, selling an estimated $9.28M.
- First Light Asset Management's ten largest holdings make up 57% of its $620M portfolio in Q3 2018.
- First Light Asset Management opened 7 new positions and closed 4 in Q3 2018.
- First Light Asset Management's portfolio value fell 3.5% quarter-over-quarter to $620M.
Based on First Light Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.